|
European Markets for Orthopedic Biomaterials 2009 (Executive Summary)Published by: iData Research, Inc. Published: Apr. 1, 2009 Table of Contents
AbstractThis is the executive summary only, extracted from the full report which is also available for purchase.In 2008, the combined European biomaterial market was worth 271.4 million. This includes hyaluronic acid viscosupplements, bone graft substitutes, BMP growth factors, autologous chondrocyte implantation and platelet/bone marrow concentration systems. Within this report, the various bone grafting materials are examined, including autografted bone, allografts, demineralized bone and synthetic bone substitutes. The market across Europe is highly dependant on regulation, reimbursement and regional supply issues. Each of these has shaped the products of preference in each country, and understanding how they interact is a vital importance in providing orthopedic biomaterials to the European market. The European market encompasses Germany, France, Italy, United Kingdom (U.K.), Spain, Benelux (Belgium, the Netherlands, and Luxemburg), Scandinavia (Finland, Denmark, Sweden and Norway), Switzerland, Austria, and Portugal. Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||